Catalyst
Slingshot members are tracking this event:
Phase 1/2 additional data for ATB200 in Pompe Disease due at 13th Annual WORLD Symposium February 13-17, 2017.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FOLD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 15, 2017
Occurred Source:
http://ir.amicusrx.com/releasedetail.cfm?ReleaseID=1012114
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1/2, Additional Data, Atb200
